Clinical Trial Update: A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 study evaluating multiple ascending doses of AZD5004 in healthy Japanese participants and individuals with Type 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD5004 (AZD5004)

Snippet

Sponsor: AstraZeneca | Conditions: Healthy Participants, Type 2 Diabetes | Phase 1 | Status: COMPLETED